000			01904nam a2200397Ia 4500
001			EBC3564276
003			MiAaPQ
005			20240121063120.0
006			m o d |
007			cr cn|||||||||
008			120711s2012 dcu sb 001 0 eng d
020			_z9780309225496
020			_z0309225493
035			_a(MiAaPQ)EBC3564276
035			_a(Au-PeEL)EBL3564276
035			_a(CaPaEBR)ebr10606357
035			_a(CaONFJC)MIL394880
035			_a(OCoLC)813285771
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRJ560 _b.C666 2012
110	2		_aCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
245	1	0	_aSafe and effective medicines for children _h[electronic resource] : _bpediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / _cCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
260			_aWashington : _bNational Academies Press, _c2012.
300			_axxiii, 408 p.
504			_aIncludes bibliographical references and index.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aPediatric pharmacology.
650		0	_aDrugs _xSafety measures.
655		4	_aElectronic books.
700	1		_aField, Marilyn J. _q(Marilyn Jane)
700	1		_aBoat, Thomas F.
710	2		_aInstitute of Medicine (U.S.). _bBoard on Health Sciences Policy.
710	2		_aNational Academies Press (U.S.)
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3564276 _zClick to View
999			_c233917 _d233917